Mid-Day Update: Stocks Rally as Weekly Jobless Claims Drop; Gold Backs Off Record

Here's where markets stand at mid-day:

-NYSE up 198.92 (+2.87%) to 7,137.15

-DJIA up 266.03 (+2.48%) to 10,985.97

-S&P 500 up 30.80 (+2.74%) to 1,151.48

-Nasdaq up 68.58 (+2.88%) to 2,449.47


Nikkei down 0.6%.

Hang Seng down 1%.

Shanghai Composite up 1.2%.

FTSE-100 down 1.1%.


NYSE Energy up 2.88% at 11,582.72

NYSE Financial up 3.44% at 4,111.09

NYSE Health Care up 2.34% at 6,320.76

NYSE Arca Tech 100 up 2.39% at 1,008.47


(+) CSCO (+14.9%) beats with results, offers mostly upbeat guidance.

(+) AAP (+9.9%) beat with earnings.

(+) COF (+5.2%) upgraded.

(+) EAT (+12.1%) beats with earnings.

(+) DIS (+2.3%) edges higher despite downgrade.

(+) KSS (+6.7%) reports stronger quarter vs year ago, lifts guidance.

(+) AMR (+3.1%) files to spin off Eagle.

(+) BUD (+3.4%) misses with revenue.

(+) CVX (+2.3%) slips despite upgrade.


(-) SLE (-3.4%) meets with earnings.

(-) AZK (-3.9%) delays study, names new CEO, reports profit up vs year ago.

(-) AMSC (-5.4%) cutting jobs.

(-) AEG (-3.3%) reports lower results vs year ago.

(-) SODA (-38.6%) beats with earnings, lifts outlook.


Stocks are higher, with the major indexes up 2% to 3% at mid-day, following a decline in the weekly unemployment claims below 400,000. Still, an unexpected rise in the trade gap raises question about U.S. economic activity. Also, investors remain concerned over the ongoing fiscal crisis in the European Union.

In a mixed bag of early data, weekly jobless claims fell, taking the four-week moving average to 405,000, the lowest since mid-April. The trade deficit unexpectedly gained in June and suggests a downward revision to second-quarter GDP growth from the initial estimate of a 1.3% annual rate.

In company news:

Shares of Gilead Sciences ( GILD ) are seeing firm support, after the company said the U.S. Food and Drug Administration approved Complera, a single-tablet regimen for the treatment of HIV-1 infection. Still, an Associated Press report this morning reports that expectations are low for the new once-per-day HIV treatment due to an increased rate of virologic failure seen in late-stage testing and doctors placed it as their third choice, according to the report.

Shares of Bank of America ( BAC ) are higher after Reuters reported that the bank may sell its stake in China Construction Bank. Bank of America has reportedly held talks with investment funds in Kuwait and Qatar about the matter, the report says.

Shares of Google ( GOOG ) are higher, while The Wall Street Journal reports that a Federal Trade Commission investigation is beginning to focus on whether the Internet giant keeps makers of Android operating system smartphones from using competitors' services. The article cites "people familiar with the probe." Further, investigators are querying whether Google give preferential placement to its own products on is website.

As part of its efforts to de-leverage the company, Liz Claiborne (LIZ) today announced it has sold the trademarks for the Curve fragrance brands and selected other smaller fragrance brands to Elizabeth Arden ( RDEN ) for $58.4 million in cash.

Shares of Exxon Mobil ( XOM ) are higher after shares were halted briefly. According to MarketWatch, the Nasdaq said the oil refiner's shares took a five minute break from trading. The report questioned whether a trading glitch was responsible/ FactSet reported that there was a trade of $63.47, which would have been a near 7% drop in the stock.

Commodities are MIXED as December gold contracts are down 1.2% to $1,763 an ounce while September crude oil contacts are up 0.23% to $83.09 a barrel.

In energy ETFs, the United States Oil Fund (USO) is up 1.76% to $32.35 and the United States Natural Gas fund (UNG) is up 2.77%, to $10.38.

In precious metal ETFs, the SPDR Gold Trust (GLD) is down 1.72% at $171.57. Market Vectors Gold Miners (GDX) is up 0.47% to $59.58. iShares Silver Trust (SLV) is down 1.81% to $37.75.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 All rights reserved. Unauthorized reproduction is strictly prohibited.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.